EFFECTIVE INHIBITION OF MYC-AMPLIFIFIED GROUP 3 MEDULLOBLASTOMA BY FACT-TARGETED CURAXIN DRUG CBL0137

被引：0
|
作者：
Wang, Jiajia [1 ]
Ma, Jie [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai, Peoples R China
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
10.1093/neuonc/noab090.024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EMBR-06
引用
收藏
页码：6 / 7
页数：2
相关论文
共 10 条
  • [1] Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137
    Wang, Jiajia
    Sui, Yi
    Li, Qifeng
    Zhao, Yang
    Dong, Xiaoshu
    Yang, Jian
    Liang, Zhuangzhuang
    Han, Yipeng
    Tang, Yujie
    Ma, Jie
    CELL DEATH & DISEASE, 2020, 11 (12)
  • [2] Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137
    Jiajia Wang
    Yi Sui
    Qifeng Li
    Yang Zhao
    Xiaoshu Dong
    Jian Yang
    Zhuangzhuang Liang
    Yipeng Han
    Yujie Tang
    Jie Ma
    Cell Death & Disease, 11
  • [3] CURAXIN CBL0137 INHIBITS THE VIABILITY OF CANCEROUS CELLS IN PRE-CLINIC MODELS OF MYC-AMPLIFIED MEDULLOBLASTOMA
    Wang, Jiajia
    Wang, Baocheng
    Zhao, Yang
    Ma, Jie
    NEURO-ONCOLOGY, 2020, 22 : 409 - 409
  • [4] A novel woodchuck model of hepatic artery infusion (HAI) with FACT complex targeted drug CBL0137
    Kim, Minhyung
    Curtin, Leslie I.
    Powers, Colin A.
    Sexton, Sandra
    Gurova, Katerina V.
    Gudkov, Andrei V.
    Iyer, Renuka V.
    CANCER RESEARCH, 2017, 77
  • [5] Novel anticancer drug curaxin CBL0137 impairs DNA methylation by eukaryotic DNA methyltransferase Dnmt3a
    Sergeev, Alexander
    Vorobyov, Andrey
    Yakubovskaya, Marianna
    Kirsanova, Olga
    Gromova, Elizaveta
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (16)
  • [6] The FACT-targeted drug CBL0137 enhances the effects of rituximab to inhibit B-cell non-Hodgkin's lymphoma tumor growth by promoting apoptosis and autophagy
    Lv, Yan
    Du, Yuxin
    Li, Kening
    Ma, Xiao
    Wang, Juan
    Du, Tongde
    Ma, Yuxin
    Teng, Yue
    Tang, Weiyan
    Ma, Rong
    Wu, Jianqiu
    Wu, Jianzhong
    Feng, Jifeng
    CELL COMMUNICATION AND SIGNALING, 2023, 21 (01)
  • [7] The FACT-targeted drug CBL0137 enhances the effects of rituximab to inhibit B-cell non-Hodgkin’s lymphoma tumor growth by promoting apoptosis and autophagy
    Yan Lv
    Yuxin Du
    Kening Li
    Xiao Ma
    Juan Wang
    Tongde Du
    Yuxin Ma
    Yue Teng
    Weiyan Tang
    Rong Ma
    Jianqiu Wu
    Jianzhong Wu
    Jifeng Feng
    Cell Communication and Signaling, 21
  • [8] Eukaryotic DNA methyltransferase Dnmt3a as one of the cellular targets of novel anticancer DNA-intercalating drug curaxin CBL0137
    Sergeev, A.
    Vorobyov, A.
    Yakubovskaya, M.
    Kirsanova, O.
    Gromova, E.
    FEBS OPEN BIO, 2021, 11 : 139 - 140
  • [9] Inhibition of the Histone Chaperone, FACT (Facilitates Chromatin Transcription) By the Novel Small Molecule CBL0137 (Curaxin) Shows Promising Efficacy in Pre-Clinical Models of Acute Myeloid Leukemia
    Portwood, Scott
    Wang, Eunice S.
    Safina, Alfiya
    Gurova, Katerina
    BLOOD, 2017, 130
  • [10] Effective Inhibition of MYC-Amplified Group 3 Medulloblastoma Through Targeting EIF4A1
    Zhao, Yang
    Li, Tiantian
    Tian, Shuaiwei
    Meng, Wei
    Sui, Yi
    Yang, Jian
    Wang, Baocheng
    Liang, Zhuangzhuang
    Zhao, Heng
    Han, Yipeng
    Tang, Yujie
    Zhang, Lei
    Ma, Jie
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12473 - 12485
1